BNP Paribas Financial Markets
RGDX

BNP Paribas Financial Markets’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

BNP Paribas Financial Markets’s Portfolio RGDX Stock Details RGDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-612
Closed -$563 – 4460
2014
Q2 		$563 Hold
612
– – ﹤0.01% 3571
2014
Q1 		$716 Hold
612
– – ﹤0.01% 2963
2013
Q4 		$710 Buy
+612
New +$1K ﹤0.01% 3891

Other funds holding RGDX

BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BNP Paribas Financial Markets's RGDX Position: Q3 2014 in Review

BNP Paribas Financial Markets sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2014, closing a stake of 612 shares — an estimated $563 sold.

BNP Paribas Financial Markets first reported a position in RGDX in Q4 2013 and held it in 3 quarters. The position peaked at $716 in Q1 2014. 18 funds tracked by Wall St. Rank hold RGDX as of Q3 2014.

  • BNP Paribas Financial Markets reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2014 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 612 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2014, an estimated $563.
  • BNP Paribas Financial Markets first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q4 2013 and held it in 3 quarters.
  • BNP Paribas Financial Markets's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $716 in Q1 2014.
  • 18 funds tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2014.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2014, filed 12 Nov 2014.